3Kuzuya T,Akanuma Y,et al. Prevalence of chronic complication in Japanese diabetic patients[J]. Diabetes Res Clin Pract,1994,24(suppl) :S159-164.
4Nasseri K,Strijers RL,Dekhuijizen LS,et al. Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy[J]. Electromyogr Clin NeurophysioX, 1998,38(5) : 295-299.
5Costa LA,Canam LH,Lisboa HR,et al. Aggregation of the metabolic syndrome is associated with inereased prevalence of chronic complications in Type 2 diabetes[J]. Diabet Med,2004,21 (3):252-255.
3Wahren J,Ekberg K,Joum H, et al. C-peptide is a bioactive pep tide[J]. Diabetologia, 2007,50 (3) : 503-509.
4Zanchetti A,Ruilope LM. Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent con trolled randomized trials? [J]. J Hypertens,2002,20:2099 -2110.
